1 in 4 Malaysians are affected by cancer — we aim to reduce that percentage.
Our researchers aim to:
Develop immunotherapy to treat lung cancers more effectively
Test whether a lower dose of checkpoint immunotherapy may be effective for Asian lung cancer patients, so that doctors can safely prescribe a more affordable dose of the treatment to more patients.
How we’ve made a difference
Identified unique cancer proteins that are found in tumour cells, which can be used to stimulate the patient’s immune system to fight cancer.
Developed a collaboration with Ministry of Health and 9 hospitals in Malaysia to test the effectiveness of lower (and more affordable) doses of immunotherapy for treatment of lung cancers.
What we’re doing now
Collaborating with biopharmaceutical partners to develop cancer vaccines for lung cancer.
Conducting a clinical trial to test the effectiveness of lower doses of immunotherapy on survival of lung cancer patients in Malaysia.